share

10-Bromo-2-Iodo-9-Methyl-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepine CAS NO 1401305-33-6


Unit Price:

CAS No.:1401305-33-6

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

10-Bromo-2-Iodo-9-Methyl-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepine is a high-purity, advanced pharmaceutical intermediate designed for research and development in medicinal chemistry. This compound is critical for the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders and other therapeutic areas. It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and academic institutions engaged in the development of new chemical entities.

Application

  • Pharmaceutical Intermediate: Key building block in the synthesis of novel benzodiazepine and oxazepine analogs for drug discovery programs.
  • Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies to optimize potency and selectivity of lead compounds.
  • CNS Drug Development: Serves as a precursor for potential therapeutics targeting neurological and psychiatric conditions.
  • Chemical Biology Probes: Utilized in the development of molecular probes to study biological pathways and protein functions.
  • Process Chemistry: Employed in route scouting and scale-up studies for the production of active pharmaceutical ingredients (APIs).
  • Academic Research: Used in university laboratories for advanced organic synthesis and heterocyclic chemistry studies.

Basic Information

Product Name 10-Bromo-2-Iodo-9-Methyl-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepine
CAS No. 1401305-33-6
Molecular Formula C13H10BrIN2O
Molecular Weight 416.04 g/mol
Synonyms 10-Bromo-2-iodo-9-methyl-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine; Benzo[f]imidazo[1,2-d][1,4]oxazepine, 10-bromo-2-iodo-9-methyl-5,6-dihydro-; 1401305-33-6; 10-Bromo-2-iodo-9-methyl-5H-benzo[f]imidazo[1,2-d][1,4]oxazepine; 9-Methyl-10-bromo-2-iodo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
EINECS Contact for details

Quality Control

Our 10-Bromo-2-Iodo-9-Methyl-5,6-Dihydrobenzo[F]Imidazo[1,2-D][1,4]Oxazepine is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity for research applications. All materials are subjected to rigorous analytical testing, including HPLC, NMR, and mass spectrometry. A comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with every shipment to support your regulatory and R&D documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive and should be handled under appropriate conditions to maintain stability. Keep the container tightly sealed when not in use to protect from moisture.

Specification

Item Specification
Appearance White to off-white solid
Identification (IR) Conforms to structure
Identification (NMR) Conforms to structure
Purity (HPLC) ≥ 95%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.